Key result
System failures drive coroners' concerns in ~31% of anticoagulant-related cardiovascular deaths.
Why the study?
Anticoagulants are important in managing cardiovascular disease, but coroners’ reports reveal safety concerns and fatal medication errors involving these drugs.
Observational (n=113)
Analysis of coroners' reports reveals recurrent systemic failures in anticoagulant management for CVD patients, highlighting a need for improved communication, record-keeping, and organizational responsiveness to prevent future deaths.
Coronial PFD analysis of anticoagulant-related CVD deaths is hypothesis-generating; prospective studies needed before practice implications.
Background The global burden of cardiovascular disease (CVD) is forecast to increase, and anticoagulants will remain important medicines for its management. Coroners’ Prevention of Future Death reports (PFDs) provide valuable insights that may enable safer and more effective use of these agents. Aim To identify CVD-related PFDs involving anticoagulants. Design and Setting Retrospective observational study of coronial case reports in England and Wales between 2013 and 2019. Method We screened 3037 PFDs for eligibility and included PFDs where CVD and an anticoagulant caused or contributed to the death. We descriptively analysed included cases and used content analysis to assess concerns raised by coroners and who responded to them. Results We identified 113 cardiovascular disease-related PFDs involving anticoagulants. Warfarin (36%), enoxaparin (11%), and rivaroxaban (11%) were the most common anticoagulants reported. Concerns most frequently raised by coroners included poor systems (31%), poor communication (25%), and failures to keep accurate medical records (25%). These concerns were most often directed to NHS trusts (29%), hospitals (10%), and general practices (8%). Nearly two-thirds (60%) of PFDs had not received responses from such organisations, which are mandatory under regulation 28 of the Coroners’ (Investigations) Regulations 2013. We created a publicly available tool, https://preventabledeathstracker.net/ , which displays coroners’ reports in England and Wales to streamline access and identify important lessons to prevent future deaths. Conclusion National organisations, healthcare professionals, and prescribers should take actions to address the concerns of coroners’ in PFDs to improve the safe use of anticoagulants in patients with cardiovascular disease. How this fits in A previous assessment of 500 PFDs identified anticoagulants as the class of drugs most often involved in fatal medication errors. This study uses innovative methods to automatically collect all available PFDs between 2013 and 2019 to identify deaths from cardiovascular disease when the use of or lack of anticoagulants caused or contributed to the death. Coroners’ raised hundreds of coroners in their reports, including issues with communication, following protocols, education and training, access to resources, and safety. Despite repeat concerns with national relevance being identified, most CVD-anticoagulant PFDs were sent locally to NHS Trusts, hospitals, and general practices, limiting their ability to reduce harms and prevent premature deaths.
No takes yet. Share an insight, caveat, or question.
Anis et al. (2021) conducted an observational in Cardiovascular disease involving anticoagulants (n=113). Anticoagulants was evaluated on Concerns raised by coroners in Prevention of Future Death reports. In 113 cardiovascular disease-related deaths involving anticoagulants, coroners most frequently raised concerns about poor systems (31%), poor communication (25%), and inaccurate medical records (25%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: